Yonsei University: Heart Failure trials

The registry lists 19 Heart Failure studies with Yonsei University as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 3 1Phase 4 2No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• HeartMate App-Based Remote Monitoring for Cardiovascular Risk Factor ManagementNot yet recruitingNCT07721584Not applicable
• In-Hospital Wearable-Based Monitoring Versus Standard Care in Cardiovascular Disease (INSPIRE)Not yet recruitingNCT07622485Not applicable
• LBBAP vs. CS Pacing for CRT in Permanent Atrial Fibrillation and Heart Failure (SYNC-AF)Not yet recruitingNCT07560891Not applicable
• Conduction System Pacing and AV Junction Ablation in Heart Failure With Atrial Fibrillation (SYNC AF-HTx)Not yet recruitingNCT07332871Not applicable
• AI-based Prediction of Cardiac Function Using Echocardiography and Body Composition Data (ECHO-FIT Study)RecruitingNCT06811519
• Relative Importance of Cardiovascular Risk Factors and Echocardiographic Parameters Affecting Left Atrial StrainRecruitingNCT05638230
• PReventive Effect Of Left Bundle Branch Area Pacing Versus righT vEntricular paCing on All Cause deaTh, Heart Failure Progression, and Ventricular dysSYNChrony in Patients With Substantial Ventricular Pacing (PROTECT-SYNC): Multicenter Prospective Randomized Controlled TrialRecruitingNCT05585411Not applicable
• Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced ElectrocardiographyCompletedNCT07515859
• SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort StudyActive, not recruitingNCT07198191
• Exploration of Clonal Hematopoiesis of Indeterminate Potential in Non-ischemic Heart Failure With Reduced Ejection FractionCompletedNCT05981144
• Validation of ERTugliflozin for Inhibiting Cardiac Fibrosis Using Cardiac MRI and Laboratory Parameters in Korean Heart Failure Patients With Nonischemic Cardiomyopathy(VERTICAL)Status unknownNCT04490681Phase 3
• Carvedilol SR Study for Biomarkers From Blood and Urine and Safety of in Patients With Heart Failure With Preserved Ejection FractionStatus unknownNCT03948685Phase 4
• Rivaroxaban Once Daily Versus Dose-adjusted Vitamin K Antagonist on the Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF)Status unknownNCT03490994Phase 4
• The Comparison With Clinical Impacts on Functional Capacity and Symptom Improvement According to the Rhythm Control in Patients With Heart Failure and Recent Onset Atrial FibrillationStatus unknownNCT02321085Not applicable
• Prospective Study on Prognosis of Cardiac Resynchronized Therapy (CRT), Implantable Cardioverter Defibrillator (ICD) Implantation in Patients With Congestive Heart Failure (CHF)Status unknownNCT02139449
• A Prospective, Single-center, Randomized, Controlled, Open-label, Pilot Study to Compare the Effectiveness and Safety of DIuretics Add-On Strategy in Acute Decompensated Heart Failure Patients (DIOS II)WithdrawnNCT02047422Not applicable
• A Prospective, Single-center, Open-label, Pilot Study to Compare the Effectiveness and Safety of Diuretics Add-On Strategy in Chronic Heart Failure Patients (DIOS 1)WithdrawnNCT01817803Not applicable
• The Role of Peritoneal Dialysis in Patients With Refractory Heart Failure and Chronic Kidney DiseaseCompletedNCT01758627Not applicable
• Study to Evaluate the Effectiveness of High Dose Statin Loading in Acute Heart Failure PatientsCompletedNCT01127945Not applicable